Strategic agreement integrates Optellum’s AI-powered lung nodule analysis with Volpara’s early cancer detection tools, enabling a more comprehensive approach to patient risk evaluation....
The acquisition adds the ultrasound-based TIVUS™ system to Boston Scientific’s interventional portfolio, enhancing treatment options for hypertension and expanding its presence in renal denervation therapy. ...
Early glaucoma detection, SightScore™ empowers eye care professionals with advanced genetic insights to identify high-risk individuals before symptoms appear, paving the way for proactive vision care....
Offering a long-acting, non-hormonal birth control option, the approval marks a significant milestone in expanding contraceptive choices for individuals seeking hormone-free alternatives. ...
New AI-driven technology accelerates infection detection in peritoneal dialysis patients, enhances air quality monitoring, and optimizes laboratory analysis across industries....
Collaboration brings clinical-grade magnetoencephalography (MEG) technology to consumers, launching first brain health center in London....
New microelectrothermoforming (μETF) method improves neural recording and stimulation, with applications in artificial retinas and brain-computer interfaces....
Six-month study demonstrates 85% symptom reduction and strong safety profile, advancing a minimally invasive solution for urgency urinary incontinence treatment. ...
The initiative enhances medical education by equipping healthcare professionals with advanced Microwave Ablation techniques to improve cancer treatment outcomes worldwide....
The initiative strengthens opioid prevention across Alabama by providing communities with vital education and at-home medication disposal solutions to reduce misuse and accidental overdoses....
